Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods

review OA: closed public-domain-us
View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-07-31

This review found evidence that hormonal and intrauterine contraceptive methods offer benefits beyond contraception, including reduced heavy menstrual bleeding, anemia, certain cancers, and improved endometriosis symptoms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Most contraceptive methods present benefits beyond contraception; however, despite a large body of evidence, many healthcare professionals (HCPs), users and potential users are unaware of those benefits. This review evaluates the evidence for non-contraceptive benefits of hormonal and non-hormonal contraceptive methods. METHODS: We searched the medical publications in PubMed, POPLINE, CENTRAL, EMBASE and LILACS for relevant articles, on non-contraceptive benefits of the use of hormonal and intrauterine reversible contraceptive methods, which were published in English between 1980 and July 2014. Articles were identified using the following search terms: 'contraceptive methods', 'benefits', 'cancer', 'anaemia', 'heavy menstrual bleeding (HMB)', 'endometrial hyperplasia', 'endometriosis' and 'leiomyoma'. RESULTS: We identified, through the literature search, evidence that some combined oral contraceptives have benefits in controlling HMB and anaemia, reducing the rate of endometrial, ovarian and colorectal cancer and ectopic pregnancy as well as alleviating symptoms of premenstrual dysphoric disorder. Furthermore, the use of the levonorgestrel-releasing intrauterine system also controls HMB and anaemia and endometrial hyperplasia and cancer, reduces rates of endometrial polyps in users of tamoxifen and alleviates pain associated with endometriosis and adenomyosis. Depot medroxyprogesterone acetate controls crises of pain associated with sickle cell disease and endometriosis. Users of the etonogestrel-releasing contraceptive implant have the benefits of a reduction of pain associated with endometriosis, and users of the copper intrauterine device have reduced rates of endometrial and cervical cancer. CONCLUSIONS: Despite the high contraceptive effectiveness of many hormonal and intrauterine reversible contraceptive methods, many HCPs, users and potential users are concerned mainly about side effects and safety of both hormonal and non-hormonal contraceptive methods, and there is scarce information about the many benefits that these methods offer beyond contraception.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Contraceptive Agents, Female Female Urogenital Diseases Intrauterine Devices, Medicated Anemia Anemia Contraception Contraception Contraceptive Agents, Female Contraceptives, Oral, Combined Contraceptives, Oral, Combined Female Female Urogenital Diseases Genital Neoplasms, Female Genital Neoplasms, Female Humans Levonorgestrel Levonorgestrel Pain Pain Pregnancy

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-01T06:12:48.306406+00:00
pubmed
last seen: 2026-05-13T22:17:52.213533+00:00
unpaywall
last seen: 2026-09-01T06:29:04.589233+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine